HR 4837, the Written Informed Consent Act, requires the Veterans Health Administration (VHA) to update its existing directive on informed consent to include additional medication classes. Specifically, it mandates that written informed consent must be obtained before prescribing antipsychotics, stimulants, antidepressants, anti-anxiety medications (anxiolytics), and narcotics (opioids) to veterans. This expansion directly affects veterans receiving these medications through the VA system, ensuring they are informed about specific treatment risks and alternatives. The key mechanism is amending VHA Directive 1005 to broaden its application beyond long-term opioid therapy to cover the newly listed medication types.
The Veteran Families Health Services Act of 2025 expands reproductive health services for military members and veterans. It requires the Department of Defense to provide fertility preservation services, including cryopreservation of reproductive genetic material before deployment or hazardous assignments for active duty service members. The bill also mandates the Department of Veterans Affairs to provide fertility treatment, counseling, and adoption assistance to veterans and their partners without regard to sex, gender identity, or sexual orientation. The law establishes coordination between military and VA health services to ensure continuity of care during the transition from active duty to veteran status. It includes provisions allowing veterans to maintain control over stored genetic material and make decisions about its use.
HR 4663, the Saving Vet Halls Act of 2025, authorizes the Department of Veterans Affairs to provide grants to eligible veterans service organizations for repairing existing facilities or upgrading technology at their locations. Organizations must submit detailed improvement plans, and grants are limited to $75,000 per year per organization, with recipients ineligible for another grant for five years. The bill explicitly prohibits using funds for new construction or facility acquisition and requires the VA to prioritize organizations based on need, plan quality, and capacity. This program, funded by $10 million annually, directly supports chartered veterans service organizations under 36 U.S.C. § 3621.
HR 4611 (EACH Act of 2025) requires all federally funded health programs - including Medicaid, Medicare, military health plans, and the Indian Health Service - to cover abortion services without restrictions, repealing the Hyde Amendment's long-standing ban on federal funding for most abortions. This directly affects millions of people enrolled in these programs, particularly low-income women, women of color (including 25% of Black women and 22% of Hispanic women on Medicaid), and young people. The bill mandates coverage in all federally administered health plans and prohibits state or private insurers from restricting abortion coverage in health insurance. It aims to eliminate current federal and state barriers that deny abortion access to people who rely on government health programs.
This bill prohibits landlords from charging application fees, tenant screening fees, and excessive late fees on "covered" rental properties - those with federally backed mortgages (like FHA, VA, or USDA loans) or HUD assistance. It caps late fees at 3% of monthly rent after a 15-day grace period and requires landlords to disclose total monthly costs, past tenant litigation, maintenance issues, and rent history for the past decade before signing leases. The law directs regulators like HUD to define "junk fees" and ban reporting unpaid fees to credit agencies. It directly affects renters in federally supported housing by limiting unexpected costs and increasing transparency.
HR 1404, the CHAMPVA Children’s Care Protection Act of 2025, expands healthcare eligibility under the CHAMPVA program for children of veterans. It increases the maximum age for children to receive medical benefits from 21 to 26 years old, regardless of marital status. This change directly affects dependent children of veterans who were previously eligible until age 21, extending coverage through their mid-twenties. The policy amendment applies to medical care provided on or after the bill’s enactment date.
The RELIEVE Act modifies veterans' access to emergency care reimbursement under VA law. It removes the requirement for veterans to have previously received VA care before qualifying for emergency treatment reimbursement during the first 60 days after enrolling in the VA healthcare system. This change directly affects new VA enrollees seeking emergency medical care within that initial 60-day window, eliminating a prior barrier to immediate coverage. The amendment applies to emergency treatment provided one year after the bill's enactment date.
HRES 967 is a non-binding resolution expressing the House's disapproval of European digital regulations like the EU's Digital Services Act and Digital Markets Act. It claims these laws unfairly burden American speech, innovation, and tech companies (citing examples like Meta and Alphabet), while harming U.S. workers and consumers. The resolution calls on the Trump administration to use diplomatic and economic tools to protect U.S. free speech rights and prevent foreign laws from undermining First Amendment principles. It also urges the Department of Justice and FTC to reject European antitrust principles and avoid cooperating with foreign enforcement of such regulations. This resolution directly affects American tech companies and free expression interests by framing European policies as a threat to U.S. digital freedoms.
The Data Care Act of 2025 requires online service providers (like social media platforms or apps that collect user data) to securely handle "individual identifying data," especially sensitive information like health details, biometrics, financial data, or precise location. It imposes three key duties: (1) reasonably securing data from breaches, (2) not misusing data to harm users or benefit themselves, and (3) restricting data sharing to third parties only with strict confidentiality contracts. The Federal Trade Commission and state attorneys general can enforce these rules through penalties for violations, with civil fines calculated based on the number of affected users or days of noncompliance. The law directly affects major digital platforms collecting user data and takes effect 180 days after enactment.
The NIH Clinical Trial Integrity Act requires NIH-funded research organizations conducting clinical trials (for drugs, devices, biological products, or behavioral interventions) to set specific, measurable diversity goals for participant recruitment and retention, focusing on race, ethnicity, age, and sex to reflect affected populations or the general U.S. population where appropriate. It mandates annual reporting of demographic data and retention rates by these groups, researcher training on diversity, and detailed plans for analyzing results across these categories. The bill also includes a study to modernize regulations on reimbursing participants' out-of-pocket costs and compensation, plus a national awareness campaign and grants to community organizations to improve outreach to underrepresented groups. This directly affects NIH-funded trial sponsors and aims to make clinical research more representative.
The PEERS Act of 2025 requires Medicare to cover peer support services provided by certified specialists at community mental health centers, rural health clinics, and other specified facilities. It directly affects Medicare beneficiaries with mental health or substance use disorders who receive these services, and providers like community mental health centers that will now bill Medicare for this care. The bill defines peer support services as non-clinical assistance focused on recovery, community integration, and self-empowerment, delivered by individuals certified after recovering from similar conditions. Coverage begins January 1, 2027.
The NIH Clinical Trial Integrity Act requires sponsors of clinical trials approved by the National Institutes of Health (NIH) to set and meet specific goals for including participants from diverse racial, ethnic, age, and sex groups. This includes submitting detailed plans for recruitment and retention - such as using telemedicine for follow-ups or flexible scheduling - and reporting annual demographic data without personally identifiable information. Trials failing to meet these goals must develop a community-informed strategic plan to improve participation, which the NIH will publish. The bill also mandates a national awareness campaign to promote diverse trial participation and a study on reducing cost barriers for participants.
